324 related articles for article (PubMed ID: 11707746)
41. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
42. Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer.
Wolfram RM; Budinsky AC; Brodowicz T; Kubista M; Köstler WJ; Kichler-Lakomy C; Hellan M; Kahlhammer G; Wiltschke C; Zielinski CC
Int J Cancer; 2000 Oct; 88(2):239-44. PubMed ID: 11004675
[TBL] [Abstract][Full Text] [Related]
43. Roles of alpha(4) integrins/VCAM-1 and LFA-1/ICAM-1 in the binding and transendothelial migration of T lymphocytes and T lymphoblasts across high endothelial venules.
Faveeuw C; Di Mauro ME; Price AA; Ager A
Int Immunol; 2000 Mar; 12(3):241-51. PubMed ID: 10700459
[TBL] [Abstract][Full Text] [Related]
44. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.
Zhu M; Terasawa H; Gulley J; Panicali D; Arlen P; Schlom J; Tsang KY
Cancer Res; 2001 May; 61(9):3725-34. PubMed ID: 11325845
[TBL] [Abstract][Full Text] [Related]
45. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking.
Peiser M; Wanner R; Kolde G
J Leukoc Biol; 2004 Sep; 76(3):616-22. PubMed ID: 15178702
[TBL] [Abstract][Full Text] [Related]
46. Porcine peripheral blood dendritic cells and natural interferon-producing cells.
Summerfield A; Guzylack-Piriou L; Schaub A; Carrasco CP; Tâche V; Charley B; McCullough KC
Immunology; 2003 Dec; 110(4):440-9. PubMed ID: 14632641
[TBL] [Abstract][Full Text] [Related]
47. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
[TBL] [Abstract][Full Text] [Related]
48. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.
Morel AS; Quaratino S; Douek DC; Londei M
Eur J Immunol; 1997 Jan; 27(1):26-34. PubMed ID: 9021994
[TBL] [Abstract][Full Text] [Related]
49. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
50. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
Damle NK; Leytze G; Klussman K; Ledbetter JA
Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
[TBL] [Abstract][Full Text] [Related]
51. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation.
McLellan AD; Heiser A; Hart DN
Immunology; 1999 Oct; 98(2):171-80. PubMed ID: 10540215
[TBL] [Abstract][Full Text] [Related]
52. Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells.
Damle NK; Klussman K; Aruffo A
J Immunol; 1992 Feb; 148(3):665-71. PubMed ID: 1346150
[TBL] [Abstract][Full Text] [Related]
53. Antibodies against sialophorin (CD43) enhance the capacity of dendritic cells to cluster and activate T lymphocytes.
Fanales-Belasio E; Zambruno G; Cavani A; Girolomoni G
J Immunol; 1997 Sep; 159(5):2203-11. PubMed ID: 9278308
[TBL] [Abstract][Full Text] [Related]
54. Expression of molecules involved in antigen presentation and T cell activation (HLA-DR, CD80, CD86, CD44 and CD54) by cultured human osteoblasts.
Reyes-Botella C; Montes MJ; Vallecillo-Capilla MF; Olivares EG; Ruiz C
J Periodontol; 2000 Apr; 71(4):614-7. PubMed ID: 10807126
[TBL] [Abstract][Full Text] [Related]
55. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells.
Spatz M; Eibl N; Hink S; Wolf HM; Fischer GF; Mayr WR; Schernthaner G; Eibl MM
Cell Immunol; 2003 Jan; 221(1):15-26. PubMed ID: 12742378
[TBL] [Abstract][Full Text] [Related]
56. Interactions of lymphocytes from patients with psoriatic arthritis or healthy controls and cultured endothelial cells.
Dunky A; Neumüller J; Menzel J
Clin Immunol Immunopathol; 1997 Dec; 85(3):297-314. PubMed ID: 9400630
[TBL] [Abstract][Full Text] [Related]
57. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
58. Cross-species costimulation: relative contributions of CD80, CD86, and CD40.
Rogers NJ; Jackson IM; Jordan WJ; Hawadle MA; Dorling A; Lechler RI
Transplantation; 2003 Jun; 75(12):2068-76. PubMed ID: 12829914
[TBL] [Abstract][Full Text] [Related]
59. A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes.
Zhu B; Liu Z; Wang P; Wu C; Xu H
Transplant Proc; 2008 Oct; 40(8):2724-8. PubMed ID: 18929846
[TBL] [Abstract][Full Text] [Related]
60. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.
McLellan AD; Sorg RV; Williams LA; Hart DN
Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
